| (2021). Sixty‐Seventh Annual Scientific Meeting of Canadian Organization of Medical Physicists. Medical Physics 48(8) , 4666-4666. 10.1002/mp.15102. |
BMIT-ID |
Conference Proceeding |
Materials |
| (2020). Scientific Abstracts and Sessions. Medical Physics 47(6) , E702-E702. 10.1002/mp.14316. |
BMIT-ID |
Conference Proceeding |
Materials |
| (2007). News and Views: Mining Environmental Problems at the Canadian Light Source. Synchrotron Radiation News 20(3) . 10.1080/08940880701401169. |
|
Magazine Article |
Materials |
| (2007). News and Views: Industrial Services and Solutions at the Canadian Light Source. Synchrotron Radiation News 20(4) . 10.1080/08940880701510811. |
|
Magazine Article |
Materials |
| (2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2. |
|
Patent |
|
| (2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B. |
|
Patent |
|
| (2018). . Patent Number: NO2968312T3. |
|
Patent |
|
| (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A. |
|
Patent |
|
| (2018). Antibody polypeptides that antagonize cd40. Patent Number: IL228720B. |
|
Patent |
|
| (2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T. |
|
Patent |
|
| (2018). Methods and compositions. Patent Number: GB201817444D0. |
|
Patent |
|
| (2018). . Patent Number: NO2699601T3. |
|
Patent |
|
| (2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A. |
|
Patent |
|
| (2018). Antibody epitope. Patent Number: IL256097A. |
|
Patent |
|
| (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A. |
|
Patent |
|